Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
Over the last 12 months, insiders at Talis Biomedical Corporation have bought $0 and sold $0 worth of Talis Biomedical Corporation stock.
On average, over the past 5 years, insiders at Talis Biomedical Corporation have bought $53.32M and sold $210,665 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $218,250 was made by BAKER BROS. ADVISORS LP () on 2021‑11‑18.
2021-11-18 | BAKER BROS. ADVISORS LP | 50,000 0.2117% | $4.37 | $218,250 | -77.36% | |||
2021-08-13 | Sale | Ramakrishnan Ramesh | 27,502 0.1055% | $7.66 | $210,665 | -71.83% | ||
2021-05-17 | Scott Randal W. | director | 11,000 0.0426% | $10.11 | $111,210 | -51.03% | ||
2021-05-14 | Scott Randal W. | director | 9,000 0.0354% | $10.16 | $91,440 | -47.52% | ||
2021-02-17 | BAKER BROS. ADVISORS LP | 6.25M 31.505% | $16.00 | $100M | -65.14% | |||
2021-02-17 | Scott Randal W. | director | 312,500 1.5752% | $16.00 | $5M | -65.14% | ||
2021-02-17 | Popovits Kimberly J | director | 5,300 0.0267% | $16.00 | $84,800 | -65.14% | ||
2021-02-17 | Posard Matthew L. | director | 62,500 0.315% | $16.00 | $1M | -65.14% | ||
2021-02-17 | Liu Douglas | Sr. Vice President, Operations | 4,000 0.0202% | $16.00 | $64,000 | -65.14% | ||
2021-02-17 | Flick Karen E. | Chief of Staff, Sr. VP, Legal | 2,000 0.0101% | $16.00 | $32,000 | -65.14% | ||
2021-02-17 | Moody John Roger Jr | Chief Financial Officer | 1,700 0.0086% | $16.00 | $27,200 | -65.14% | ||
2021-02-17 | Ramakrishnan Ramesh | Sr. Vice President, R&D | 1,000 0.005% | $16.00 | $16,000 | -65.14% |
BAKER BROS. ADVISORS LP | 7053176 22.2619% | $8.50 | 2 | 0 | <0.0001% | |
Popovits Kimberly J | director | 215090 0.6789% | $8.50 | 1 | 0 | <0.0001% |
Posard Matthew L. | director | 62500 0.1973% | $8.50 | 1 | 0 | <0.0001% |
Ramakrishnan Ramesh | 38619 0.1219% | $8.50 | 1 | 1 | <0.0001% | |
Scott Randal W. | director | 20000 0.0631% | $8.50 | 3 | 0 | <0.0001% |
Liu Douglas | Sr. Vice President, Operations | 4000 0.0126% | $8.50 | 1 | 0 | <0.0001% |
Flick Karen E. | Chief of Staff, Sr. VP, Legal | 2000 0.0063% | $8.50 | 1 | 0 | <0.0001% |
Moody John Roger Jr | Chief Financial Officer | 1700 0.0054% | $8.50 | 1 | 0 | <0.0001% |
Baker Bros Advisors LP | $4.45M | 27.9 | 508,323 | 0% | +$0 | 0.06 | |
Bml Capital Management Llc | $374,001.00 | 2.35 | 42,743 | 0% | +$0 | 0.29 | |
The Vanguard Group | $271,364.00 | 1.7 | 31,013 | 0% | +$0 | <0.0001 | |
Susquehanna International Group | $152,521.00 | 0.96 | 17,431 | +11.95% | +$16,274.97 | <0.0001 | |
Prelude Capital | $130,620.00 | 0.82 | 14,928 | 0% | +$0 | 0.01 | |
Geode Capital Management | $104,077.00 | 0.65 | 11,890 | +5.41% | +$5,339.53 | <0.0001 | |
Renaissance Technologies | $90,000.00 | 0.57 | 10,299 | New | +$90,000.00 | <0.0001 | |
BlackRock | $41,221.00 | 0.26 | 4,711 | -54.84% | -$50,058.45 | <0.0001 | |
Tower Research Capital | $8,111.00 | 0.05 | 927 | -6.17% | -$533.73 | <0.0001 | |
Morgan Stanley | $5,556.00 | 0.04 | 635 | +71.16% | +$2,309.90 | <0.0001 | |
UBS | $1,051.00 | 0.01 | 120 | -5.51% | -$61.31 | <0.0001 | |
Advisor Group Holdings Inc | $1,067.00 | 0.01 | 122 | +16.19% | +$148.68 | <0.0001 | |
Wells Fargo | $114.00 | <0.01 | 13 | 0% | +$0 | <0.0001 | |
Larson Financial Group Llc | $123.00 | <0.01 | 14 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $26.00 | <0.01 | 3 | +50% | +$8.67 | <0.0001 | |
Qube Research & Technologies | $18.00 | <0.01 | 2 | 0% | +$0 | <0.0001 |